Longevity Health Holdings, Inc. (XAGEW)
2025-06-30 | ||||
|---|---|---|---|---|
| Net sales | 503,612 | |||
| Cost of sales | 200,954 | |||
| Gross profit | 302,658 | |||
| General and administrative | 1,564,967 | |||
| Selling and marketing | 345,505 | |||
| Research and development | 228,606 | |||
| Depreciation and amortization of intangible assets | 22,184 | |||
| Total operating expenses | 2,161,262 | |||
| Loss from operations | -1,858,604 | |||
| Loss on forward purchase agreement | - | |||
| Change in fair value of earnout liabilities | 29,630 | |||
| Other income | 4,357 | |||
| Interest expense | 2,561 | |||
| Amortization of debt discount | - | |||
| Total other income (expense) | -27,834 | |||
| Loss from continuing operations before income taxes | -1,886,438 | |||
| Income tax benefit | - | |||
| Loss from continuing operations | -1,886,438 | |||
| Loss from discontinued operations | - | |||
| Gain on sale of discontinued operations | - | |||
| Net loss | -1,886,438 | |||
| Basic net income (loss) per share | -1.56 | |||
| Diluted net income (loss) per share | -1.56 | |||
| Weighted average shares outstanding, basic | 1,209,809 | |||
| Weighted average shares outstanding, diluted | 1,209,809 | |||